Patient Outcomes With Use of Computed Tomography Angiography in Acute Ischemic Stroke and Transient Ischemic Attack: A Systematic Review and Meta-Analysis

被引:1
作者
Li, Siying [1 ]
Trajkovski, Aleksandar [2 ]
Siarkowski, Michael [3 ,4 ]
Santiago, Calvin [5 ]
Eng, Kevin A. [6 ]
Kishibe, Teruko [7 ]
Umakanthan, Athithyan [8 ]
Lang, Eddy [9 ]
机构
[1] Univ British Columbia, Emergency Med, Vancouver, BC, Canada
[2] Dalhousie Univ, Family Med, Halifax, NS, Canada
[3] Univ Calgary, Biomed Technol, Calgary, AB, Canada
[4] Univ British Columbia, Dent, Vancouver, BC, Canada
[5] Univ Toronto, Neurol, Toronto, ON, Canada
[6] Western Univ, Radiol, London, ON, Canada
[7] St Michaels Hosp, Scotiabank Hlth Sci Lib, Toronto, ON, Canada
[8] Western Univ, Schulich Sch Med & Dent, Epidemiol & Publ Hlth, London, ON, Canada
[9] Univ Calgary, Emergency Med, Calgary, AB, Canada
关键词
stroke; ischemic stroke; transient ischemic attack; tia; computed tomography angiography; ct angiography; cta; CT; SCALE; GUIDELINES; QUALITY; TIME;
D O I
10.7759/cureus.8187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives It remains uncertain whether computed tomography angiography (CTA) in ischemic strokes and transient ischemic attacks (TIAs) benefits patient outcomes beyond those eligible for endovascular therapy. We conducted a systematic review and meta-analysis of observational studies and randomized controlled trials (RCTs) investigating the use of CTA against other imaging modalities for recurrent stroke, mortality, disability, emergency department (ED) revisits, or changes in management in ischemic stroke and TIA. (PROSPERO: 349590) Methods MEDLINE, Embase, and CENTRAL were searched. We included studies evaluating CTA against non-CTA imaging modalities for outcomes of interest in ischemic stroke or TIA. Two reviewers extracted data and assessed study quality. Data were pooled by the generic inverse variance method. Heterogeneity was assessed using Cochran's Q statistic and quantified by I-2. Quality of the evidence was assessed by GRADE. Results We found 12 eligible cohort studies involving 17,481 patients, and no eligible RCTs. No changes were detected in recurrent stroke, mortality, or disability when CTA was compared against pooled imaging modalities, nor compared to non-contrast computed tomography (NCCT) alone. The evidence for each outcome was graded as low quality to very low quality. Conclusions CTA use was not associated with significant reductions in recurrent stroke, mortality, or disability in ischemic stroke and TIA patient compared with other imaging modalities. More high-quality studies are needed.
引用
收藏
页数:26
相关论文
共 30 条
  • [1] [Anonymous], ONLINE STAT ED INTER
  • [2] Atchaneeyasakul K, 2017, INTERV NEUROL, V6, P147, DOI 10.1159/000464300
  • [3] Safety of performing CT angiography in stroke patients treated with intravenous thrombolysis
    Aulicky, P.
    Mikulik, R.
    Goldemund, D.
    Reif, M.
    Dufek, M.
    Kubelka, T.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (07) : 783 - 787
  • [4] Added value of multimodal computed tomography imaging: analysis of 1994 acute ischaemic strokes
    Bill, O.
    Faouzi, M.
    Meuli, R.
    Maeder, P.
    Wintermark, M.
    Michel, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (01) : 167 - 174
  • [5] Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018
    Boulanger, J. M.
    Lindsay, M. P.
    Gubitz, G.
    Smith, E. E.
    Stotts, G.
    Foley, N.
    Bhogal, S.
    Boyle, K.
    Braun, L.
    Goddard, T.
    Heran, M. K. S.
    Kanya-Forster, N.
    Lang, E.
    Lavoie, P.
    McClelland, M.
    O'Kelly, C.
    Pageau, P.
    Pettersen, J.
    Purvis, H.
    Shamy, M.
    Tampieri, D.
    vanAdel, B.
    Verbeek, R.
    Blacquiere, D.
    Casaubon, L.
    Ferguson, D.
    Hegedus, Y.
    Jacquin, G. J.
    Kelly, M.
    Kamal, N.
    Linkewich, B.
    Lum, C.
    Mann, B.
    Milot, G.
    Newcommon, N.
    Poirier, P.
    Simpkin, W.
    Snieder, E.
    Trivedi, A.
    Whelan, R.
    Eustace, M.
    Smitko, E.
    Butcher, K.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2018, 13 (09) : 949 - 984
  • [6] CanadianStrokeBestPracticeRecommendations: Hyperacute Stroke Care Guidelines, Update 2015
    Casaubon, Leanne K.
    Boulanger, Jean-Martin
    Blacquiere, Dylan
    Boucher, Scott
    Brown, Kyla
    Goddard, Tom
    Gordon, Jacqueline
    Horton, Myles
    Lalonde, Jeffrey
    LaRiviere, Christian
    Lavoie, Pascale
    Leslie, Paul
    McNeill, Jeanne
    Menon, Bijoy K.
    Moses, Brian
    Penn, Melanie
    Perry, Jeff
    Snieder, Elizabeth
    Tymianski, Dawn
    Foley, Norine
    Smith, Eric E.
    Gubitz, Gord
    Hill, Michael D.
    Glasser, Ev
    Lindsay, Patrice
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (06) : 924 - 940
  • [7] Does the Application of X-Ray Contrast Agents Impair the Clinical Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients?
    Dzialowski, Imanuel
    Puetz, Volker
    Buchan, Alastair M.
    Demchuk, Andrew M.
    Hill, Michael D.
    [J]. STROKE, 2012, 43 (06) : 1567 - 1571
  • [8] Is vascular imaging valuable prior to administration of intravenous tissue plasminogen activator?
    Eichel, Roni
    Cohen, Jose E.
    Gomori, John M.
    Ben-Hur, Tamir
    Keigler, Galina
    Leker, Ronen R.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (10) : 1691 - 1694
  • [9] Functional outcome 3 months after stroke predicts long-term survival
    Eriksson, Marie
    Norrving, Bo
    Terent, Andreas
    Stegmayr, Birgitta
    [J]. CEREBROVASCULAR DISEASES, 2008, 25 (05) : 423 - 429
  • [10] Survival and recurrent strokes in patients with different subtypes of stroke: A fourteen-year follow-up study
    Eriksson, SE
    Olsson, JE
    [J]. CEREBROVASCULAR DISEASES, 2001, 12 (03) : 171 - 180